September 27, 2007 09:22 ET

Emerging Equity Alert for Thursday, September 27, 2007: RHGP Announces Earnings and 175% Growth!

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Peter Antipatis of Capital Research Group Inc.

WESTON, FL--(Marketwire - September 27, 2007) - Announces the following stocks to its Breaking News List: Renhuang Pharmaceuticals, Inc. (OTCBB: RHGP), Atmel Corporation (NASDAQ: ATML), China BAK Battery, Inc. (NASDAQ: CBAK), Cyberlux Corp. (OTCBB: CYBL).

Renhuang Pharmaceuticals, Inc. (OTCBB: RHGP), a leading integrated developer, manufacturer and distributor of a broad line of high-quality nutraceutical, natural medicinal and bio-pharmaceutical products in China, reported its results for the third quarter and nine months ending July 31, 2007. Fiscal nine months year-to-date total net income was $8.46 million, up 175% compared to the net income of $3.08 million for the Company's operating subsidiary for the same period last year.

The Company showed net income of $8.46 million on revenues of $20,890,656, achieving a net profit margin of 40 percent, in its seasonally slowest quarter! RHGP has been lying low, but is just starting an intense public relations campaign to showcase the Company's earnings and growth potential. At current share prices, the stock is trading at less than 5 times CURRENT earnings! And with cash on hand of over $9.5 million, adding in short and long term assets, the stock is approaching book value! Investors should take heed, other stocks in this space are carrying PE's of 20, 30, and even 40+ times earnings. Valuations like these may not last long!

Other stocks highlighted include Atmel Corporation (NASDAQ: ATML): Hot Stocks List, down 1% on 5 million shares, China BAK Battery, Inc. (NASDAQ: CBAK): Hot Stocks List, up 46% on 16 million shares, Cyberlux Corp. (OTCBB: CYBL): Hot Stocks List, up 49% on 84 million shares.'s Daily Stock Updates:, a leader in corporate communications and finance, highlights stocks that are in the news, have traded high volume, or experienced a large change in price in recent sessions. The aforementioned commentary is not meant to be indicative of a “long term” view of any of the companies listed. For more go to

All material herein was prepared by CRG Partners, Inc. (CRGP) based upon information believed to be reliable. The information contained herein is not guaranteed by CRGP to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. CRGP is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. CRGP has been compensated by third party shareholders with shares or with cash from the company on behalf of one or more of the companies mentioned in this opinion. CRGP has been compensated twenty thousand shares for RHGP, and expects to receive an additional twenty thousand shares in future installments. CRG was previously compensated fifty five thousand shares for RHGP, and has sold those shares. CRGP may sell its shares for less than the target price given in this opinion. In addition to any compensation mentioned above, additional compensation can be equal to ten percent of any newly issued or registered securities of the profiled companies. CRGP and its web site are operated under a license from Capital Research Group, Inc., Inc. and One Source Solutions Inc. (Licensors) and CRGP is not the agent of any of the Licensors and CRGP is solely responsible for all statements made herein. CRGP's affiliates, officers, directors and employees intend to buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. CRGP will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

Contact Information